Literature DB >> 28837878

miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells.

Wei Cai1, Haitao Jiang1, Yifan Yu1, Yong Xu1, Wenshan Zuo1, Shouguo Wang1, Zhen Su2.   

Abstract

Recently, miR-367 is reported to exert either oncogenic or tumor suppressive effects in human malignancies. Recent study reports that miR-367 is up-regulated in OS tissues and cell lines, and abrogates adriamycin-induced apoptosis. The clinical significance of miR-367 and its function in OS need further investigation. In our study, miR-367 expression in OS was markedly elevated compared with corresponding non-tumor tissues. High miR-367 expression was associated with malignant clinical features and poor prognosis of OS patients. In accordance, the levels of miR-367 were dramatically up-regulated in OS cells. Loss of miR-367 expression in Saos-2 cells obviously inhibited the proliferation, migration and invasion of cancer cells in vitro. Meanwhile, miR-367 restoration promoted these malignant behaviors of MG-63 cells. Mechanistically, miR-367 negatively regulated DOC-2/DAB2 interactive protein (DAB2IP) abundance in OS cells. Hereby, DAB2IP was recognized as a direct target gene of miR-367 in OS. DAB2IP mRNA level was down-regulated and inversely correlated with miR-367 expression in OS specimens. DAB2IP overexpression prohibited proliferation, migration and invasion in Saos-2 cells, while DAB2IP knockdown showed promoting effects on proliferation, migration and invasion of MG-63 cells. Furthermore, the role of miR-367 might be mediated by DAB2IP-regulated phosphorylation of ERK and AKT in OS cells. To conclude, miR-367 may function as a biomarker for prediction of prognosis and a target for OS therapy.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  DOC-2/DAB2 interactive protein; Metastasis; Osteosarcoma; Tumor growth; microRNA-367

Mesh:

Substances:

Year:  2017        PMID: 28837878     DOI: 10.1016/j.biopha.2017.07.158

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.

Authors:  Carolini Kaid; Dione Jordan; Heloisa Maria de Siqueira Bueno; Bruno Henrique Silva Araujo; Amanda Assoni; Oswaldo Keith Okamoto
Journal:  Mol Oncol       Date:  2019-08-22       Impact factor: 6.603

3.  MicroRNA-367 directly targets PIK3R3 to inhibit proliferation and invasion of oral carcinoma cells.

Authors:  Haitao Sun; Xiaodong Feng
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

4.  Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis.

Authors:  Hui Liu; Yuan Liu; Zhaolian Bian; Jing Zhang; Rui Zhang; Xiaoyu Chen; Yanxia Huang; Yang Wang; Jinshui Zhu
Journal:  Mol Cancer       Date:  2018-10-18       Impact factor: 27.401

5.  miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.

Authors:  Jun Wan; Xiean Ling; Bin Peng; Guanggui Ding
Journal:  Oncol Rep       Date:  2018-05-16       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.